1. Home
  2. ADMA vs NNI Comparison

ADMA vs NNI Comparison

Compare ADMA & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • NNI
  • Stock Information
  • Founded
  • ADMA 2004
  • NNI 1978
  • Country
  • ADMA United States
  • NNI United States
  • Employees
  • ADMA N/A
  • NNI N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • NNI Finance: Consumer Services
  • Sector
  • ADMA Health Care
  • NNI Finance
  • Exchange
  • ADMA Nasdaq
  • NNI Nasdaq
  • Market Cap
  • ADMA 4.1B
  • NNI 4.0B
  • IPO Year
  • ADMA N/A
  • NNI 2003
  • Fundamental
  • Price
  • ADMA $21.31
  • NNI $104.78
  • Analyst Decision
  • ADMA Strong Buy
  • NNI Hold
  • Analyst Count
  • ADMA 4
  • NNI 1
  • Target Price
  • ADMA $22.50
  • NNI $98.00
  • AVG Volume (30 Days)
  • ADMA 3.7M
  • NNI 62.1K
  • Earning Date
  • ADMA 05-08-2025
  • NNI 05-08-2025
  • Dividend Yield
  • ADMA N/A
  • NNI 1.07%
  • EPS Growth
  • ADMA N/A
  • NNI 109.22
  • EPS
  • ADMA 0.81
  • NNI 5.02
  • Revenue
  • ADMA $426,454,000.00
  • NNI $1,354,961,000.00
  • Revenue This Year
  • ADMA $18.45
  • NNI $11.81
  • Revenue Next Year
  • ADMA $26.96
  • NNI $4.36
  • P/E Ratio
  • ADMA $26.31
  • NNI $20.87
  • Revenue Growth
  • ADMA 65.16
  • NNI 15.70
  • 52 Week Low
  • ADMA $6.01
  • NNI $93.59
  • 52 Week High
  • ADMA $23.64
  • NNI $127.32
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 60.16
  • NNI 40.70
  • Support Level
  • ADMA $17.30
  • NNI $100.00
  • Resistance Level
  • ADMA $22.25
  • NNI $106.82
  • Average True Range (ATR)
  • ADMA 1.50
  • NNI 3.37
  • MACD
  • ADMA 0.16
  • NNI -0.06
  • Stochastic Oscillator
  • ADMA 83.62
  • NNI 48.39

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.

Share on Social Networks: